如果您對這些純文本內容做了任何改變,很快就會看到。

個人檔案

經歷

  • 2009-2010 Intern, National Taiwan University Hospital, Taipei
  • 2010-2013 Resident, Department of Internal Medicine, National Taiwan University, Taipei
  • 2013-2015 Cardiology Fellow, Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei
  • 2015–2016 Visiting Staff of Division of Cardiology, Department of Internal Medicine, Chiali Chi Mei Medical Center, Tainan, Taiwan
  • 2016 Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch
  • 2017- Visiting Staff of Division of Cardiology, Department of Internal Medicine, Taipei Medical University, Shuang Ho hospital, Ministry of Health and Welfare

研究興趣

  • Critical care medicine
  • Heart failure
  • dyslipidemia
  • coronary artery disease
  • hypertension
  • pregnancy related heart disease

其它

  • Board of Physician
  • Board of Internal Medicine
  • Board certification of Cardiology
  • Board certification of Cardiovascular Interventions

指紋 查看啟用 YiWei Chung 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。

  • 2 類似的檔案
Spironolactone Medicine & Life Sciences
Renal Replacement Therapy Medicine & Life Sciences
Critical Care Medicine & Life Sciences
Dyslipidemias Medicine & Life Sciences
Atrial Fibrillation Medicine & Life Sciences
Coronary Artery Disease Medicine & Life Sciences
Heart Diseases Medicine & Life Sciences
Heart Failure Medicine & Life Sciences

網絡 國家層面的近期外部合作。點選圓點深入探索詳細資料。

研究成果 2016 2016

  • 4 引文
  • 1 h-指數
  • 1 文章
4 引文 (Scopus)

Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy

Chung, Y. W., Yang, Y. H., Wu, C. K., Yu, C. C., Juang, J. M. J., Wang, Y. C., Tsai, C. T., Lin, L. Y., Lai, L. P., Hwang, J. J., Chiang, F. T., Chen, P. C. & Lin, J. L., 一月 1 2016, 於 : International Journal of Cardiology. 202, p. 962-966 5 p.

研究成果: 雜誌貢獻文章

Spironolactone
Renal Replacement Therapy
Atrial Fibrillation
Dialysis
Catastrophic Illness